statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	374
SG - Singapore	136
IT - Italia	129
CN - Cina	79
HK - Hong Kong	60
KR - Corea	54
IN - India	52
BR - Brasile	40
NZ - Nuova Zelanda	39
DE - Germania	37
GB - Regno Unito	33
IE - Irlanda	20
FR - Francia	18
JP - Giappone	18
VN - Vietnam	18
FI - Finlandia	17
BE - Belgio	13
CL - Cile	13
NL - Olanda	13
RU - Federazione Russa	12
CA - Canada	11
TR - Turchia	11
SE - Svezia	10
ES - Italia	9
BD - Bangladesh	6
AE - Emirati Arabi Uniti	5
AU - Australia	5
ID - Indonesia	5
IQ - Iraq	5
MX - Messico	5
PL - Polonia	5
UA - Ucraina	5
UZ - Uzbekistan	5
CO - Colombia	4
LU - Lussemburgo	4
PK - Pakistan	4
ZA - Sudafrica	4
IL - Israele	3
IR - Iran	3
PT - Portogallo	3
TW - Taiwan	3
AR - Argentina	2
CZ - Repubblica Ceca	2
LT - Lituania	2
RO - Romania	2
UY - Uruguay	2
AM - Armenia	1
AO - Angola	1
AT - Austria	1
BG - Bulgaria	1
EG - Egitto	1
GH - Ghana	1
GT - Guatemala	1
JO - Giordania	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LV - Lettonia	1
MM - Myanmar	1
MY - Malesia	1
NP - Nepal	1
PH - Filippine	1
PS - Palestinian Territory	1
PY - Paraguay	1
SA - Arabia Saudita	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
VE - Venezuela	1
Totale	1.324

Nome	#
Dissecting the pathophysiology of alpha-synuclein and synapsin III interaction in conventional and patient-derived models of Parkinson’s disease	580
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders	128
The good and bad of therapeutic strategies that directly target α-synuclein	120
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice	95
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?	94
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease	82
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease	82
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype	82
Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brain	73
Totale	1.336

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	4	0	0	0	0	0	0	0	0	0	0	1	3
2021/2022	40	0	0	6	1	0	9	0	6	3	3	6	6
2022/2023	77	3	0	0	1	0	6	1	11	17	14	15	9
2023/2024	265	26	26	16	18	8	34	30	13	29	17	30	18
2024/2025	389	22	15	22	32	33	30	61	30	30	40	47	27
2025/2026	522	50	45	31	77	78	47	67	27	41	40	19	0
Totale													1.336